Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Your search for Momelotinib (Omijara) returned no results
Showing 1 result for momelotinib (omjjara)

  1. Momelotinib for treating myelofibrosis-related splenomegaly or symptoms (TA957)

    Evidence-based recommendations on momelotinib (Omjjara) for treating myelofibrosis-related splenomegaly or symptoms in adults.

    Technology appraisal guidance
    Published
    20 March 2024
    View recommendations

    Sections for TA957